Delivery Order HHSN272201600006I-HHSN27200002
Award Date 8/7/17
Potential Completion Date 2/3/20
Potential Value $816K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $799,780 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for the development of analytical methods, upstream and downstream manufacturing processes, scale-up production, and release testing for the LNA14 product. This delivery order falls under a larger...
- This is a prime contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The $14,898,362.53 cost-plus-fixed-fee contract is for biomedical research and development. It has a period of performance through December 31, 2011 and does not have a set-aside designation. Resilience Government Services is a technology-focused...
- This is a $3,044,549.00 fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for biomedical research and development work, with a period of performance ending on March 31, 2010. No set-aside designations were used. Resilience Government Services, a technology-focused biomanufacturing company, has...
- This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $29,026,970.00 cost-plus-fixed-fee contract was awarded on September 9, 2019 to perform work under HHS-NIH-NIAID-BAA2018. The contract has an ultimate completion date of August 17, 2024 and does not have a set-aside designation....
- This is a $1,040,997.51 cost-plus-fixed-fee definitive contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The contract is for PMR (Performance Monitoring and Reporting) and PMC (Performance Measurement Criteria) services, with a period of performance ending on July 31, 2021. Resilience, a technology-focused biomanufacturing company, has previously...
- This is a definitive contract awarded by the Department of the Army's Joint PEO Chemical and Biological Defense, a defense agency, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $366,290,602.35 cost-plus-fixed-fee contract is for the Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) Capability, with a period of performance through October 31, 2023. As a prime contractor, Resilience has provided a range of goods and services related...
- This federal contract award, W911QY2190008, was issued by the Joint PEO Chemical and Biological Defense, a subcomponent of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 Other Transaction Agreement is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. Resilience Government Services, a technology-focused biomanufacturing company, has previously received federal...
- This is a $190,241,861.21 Other Transaction Agreement awarded by the Department of the Army's Joint PEO Chemical and Biological Defense to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.), a technology-focused biomanufacturing company. The contract does not have a set-aside designation. The agreement, awarded on February 21, 2020, supports the development and manufacturing of medical countermeasures against biological threats and COVID-19. Resilience has provided...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $8,363,045 Other Transaction Agreement to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., for the prototype development of a monoclonal antibody (MAB) countermeasure designated VRC114. The contract does not have a set-aside designation. Resilience Government Services is a technology-focused biomanufacturing company that has previously supported the Department...
- The U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense awarded a delivery order valued at $4.86 million to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) on June 16, 2022, with completion targeted for February 28, 2025. This cost-plus-fixed-fee delivery order supports research and development activities focused on developing an FDA-licensed monoclonal antibody countermeasure for botulinum neurotoxin exposure. The work...